Galectin 9 and PINCH, novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptides.
about
Induction of HLA-A*33-restricted cytotoxic lymphocytes against renal cell carcinoma targeting galectin 9 and PINCH.Galectin Targeted Therapy in Oncology: Current Knowledge and Perspectives.Present and future perspectives on immunotherapy for advanced renal cell carcinoma: Going to the core or beating around the bush?Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma.
P2860
Galectin 9 and PINCH, novel immunotherapy targets of renal cell carcinoma: a rationale to find potential tumour antigens and the resulting cytotoxic T lymphocytes induced by the derived peptides.
description
2014 nî lūn-bûn
@nan
2014 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Galectin 9 and PINCH, novel im ...... duced by the derived peptides.
@ast
Galectin 9 and PINCH, novel im ...... duced by the derived peptides.
@en
type
label
Galectin 9 and PINCH, novel im ...... duced by the derived peptides.
@ast
Galectin 9 and PINCH, novel im ...... duced by the derived peptides.
@en
prefLabel
Galectin 9 and PINCH, novel im ...... duced by the derived peptides.
@ast
Galectin 9 and PINCH, novel im ...... duced by the derived peptides.
@en
P2093
P2860
P356
P1433
P1476
Galectin 9 and PINCH, novel im ...... duced by the derived peptides.
@en
P2093
Aiko Obayashi
Hidenori Kawashima
Junji Uchida
Katsuyuki Kuratsukuri
Marie Kawamura
Sakae Masaki
Satoshi Tamada
Taro Iguchi
Tatsuya Nakatani
Tomoaki Tanaka
P2860
P304
P356
10.1111/BJU.12499
P577
2014-02-01T00:00:00Z